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Background
HIV-specific T cell dysfunction is a prominent feature of
HIV infection. We have reported that the PD-1 and IL-10
pathways mediate a reversible impairment of HIV-specific
proliferative T cell responses. However, the responses are
frequently modest and not all infected subjects respond to
blockade of either pathway. It is therefore crucial to deter-
mine whether combined PD-L1 and IL-10Rα blockade
can overcome these limitations and synergistically revive
HIV-specific T cell responses.
Methods
We investigated 17 persons with HIV infection that were
divided into groups according to treatment status. We
used Luminex arrays to measure IFN-γ and IL-2 secretion
in supernatants of CD8-depleted PBMC stimulated for 48
h with a Gag peptide pool or left unstimulated in the pres-
ence of isotype control antibody, anti-PD-L1, anti-IL-
10Rα or combined blockade.
Results
In viremic individuals (n = 10), blockade of a single or
two inhibitory pathways resulted in a significant increase
in IFNγ secretion by HIV-specific CD4 T cells when com-
pared to the isotype control condition (p < 0.0001, Fried-
man test with Dunn's post-test). The median fold-increase
in IFN-γ secretion was 1.8 for PD-L1, 5.1 for IL-10Rα and
13.4 for combined blockade. In subjects with higher viral
loads, combined PD-L1/IL-10Rα blockade resulted in an
occasionally dramatic synergistic effect, even when a lim-
ited increase was seen with PD-L1 blockade alone. We
also observed a non-significant trend toward increased IL-
2 secretion upon inhibitory blockade. In contrast, in
aviremic subjects, IL-10Rα blockade was not more effec-
tive than PD-L1 blockade, and additive effects of com-
bined blockade were inconstant.
Conclusion
These data indicate that combined blockade of the PD-1
and IL-10 pathways synergize to restore effector functions
of HIV specific CD4 T cells and demonstrate the potential
of targeting multiple inhibitory pathways to reverse T cell
exhaustion in humans. These results may have significant
implications for development of novel immunotherapeu-
tic interventions.
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